Journal of Molecular and Cellular Cardiology
Volume 50, Issue 1 , Pages 16-24 , January 2011

Survivin: A novel player in insulin cardioprotection against myocardial ischemia/reperfusion injury

  • Rui Si

      Affiliations

    • Department of Physiology and Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China
    • These two authors contributed equally to this work.
    • ,
  • Ling Tao

      Affiliations

    • Department of Physiology and Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China
    • These two authors contributed equally to this work.
    • ,
  • Hai F. Zhang

      Affiliations

    • Department of Physiology, Fourth Military Medical University, Xi'an, China
    • ,
  • Qiu J. Yu

      Affiliations

    • Department of Physiology and Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China
    • ,
  • Rui Zhang

      Affiliations

    • Department of Biochemistry and Molecular Biology, Fourth Military Medical University, Xi'an, China
    • ,
  • An L. Lv

      Affiliations

    • Department of Physiology and Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China
    • ,
  • Ning Zhou

      Affiliations

    • Department of Physiology and Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China
    • ,
  • Feng Cao

      Affiliations

    • Department of Physiology and Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China
    • ,
  • Wen Y. Guo

      Affiliations

    • Department of Physiology and Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China
    • ,
  • Jun Ren

      Affiliations

    • University of Wyoming College of Health Sciences, Laramie, WY, USA
    • ,
  • Hai C. Wang

      Affiliations

    • Department of Physiology and Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China
    • Corresponding Author InformationCorresponding authors. F. Gao is to be contacted at Department of Physiology and Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China. Tel.: +86 29 84776423; fax: +86 29 83246270. H.C. Wang, tel.: +86 29 84773469; fax: +86 29 84775183.
    • ,
  • Feng Gao

      Affiliations

    • Department of Physiology and Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China
    • Department of Physiology, Fourth Military Medical University, Xi'an, China
    • Corresponding Author InformationCorresponding authors. F. Gao is to be contacted at Department of Physiology and Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China. Tel.: +86 29 84776423; fax: +86 29 83246270. H.C. Wang, tel.: +86 29 84773469; fax: +86 29 84775183.

Received 23 February 2010 ,Revised 18 August 2010 ,Accepted 18 August 2010.

References 

  1. Braunwald E, Kloner RA. Myocardial reperfusion: a double-edged sword?. J Clin Invest. 1985;76:1713–1719
  2. Ambrosio G, Tritto I. Reperfusion injury: experimental evidence and clinical implications. Am Heart J. 1999;138:S69–S75
  3. Yellon DM, Baxter GF. Protecting the ischaemic and reperfused myocardium in acute myocardial infarction: distant dream or near reality?. Heart. 2000;83:381–387
  4. Gao F, Gao E, Yue TL, Ohlstein EH, Lopez BL, Christopher TA, et al. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia–reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation. 2002;105:1497–1502
  5. Freude B, Masters TN, Robicsek F, Fokin A, Kostin S, Zimmermann R, et al. Apoptosis is initiated by myocardial ischemia and executed during reperfusion. J Mol Cell Cardiol. 2000;32:197–208
  6. Aikawa R, Nawano M, Gu Y, Katagiri H, Asano T, Zhu W, et al. Insulin prevents cardiomyocytes from oxidative stress-induced apoptosis through activation of PI3 kinase/Akt. Circulation. 2000;102:2873–2879
  7. Ma H, Zhang HF, Yu L, Zhang QJ, Li J, Huo JH, et al. Vasculoprotective effect of insulin in the ischemic/reperfused canine heart: role of Akt-stimulated NO production. Cardiovasc Res. 2006;69:57–65
  8. Jonassen AK, Sack MN, Mjos OD, Yellon DM. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res. 2001;89:1191–1198
  9. Hausenloy DJ, Yellon DM. New directions for protecting the heart against ischaemia–reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)–pathway. Cardiovasc Res. 2004;61:448–460
  10. Conte MS, Altieri DC. Survivin regulation of vascular injury. Trends Cardiovasc Med. 2006;16:114–117
  11. Kaga S, Zhan L, Altaf E, Maulik N. Glycogen synthase kinase-3beta/beta-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium. J Mol Cell Cardiol. 2006;40:138–147
  12. Yao LL, Wang YG, Cai WJ, Yao T, Zhu YC. Survivin mediates the anti-apoptotic effect of delta-opioid receptor stimulation in cardiomyocytes. J Cell Sci. 2007;120:895–907
  13. Fukuda S, Kaga S, Sasaki H, Zhan L, Zhu L, Otani H, et al. Angiogenic signal triggered by ischemic stress induces myocardial repair in rat during chronic infarction. J Mol Cell Cardiol. 2004;36:547–559
  14. Ma XL, Kumar S, Gao F, Louden CS, Lopez BL, Christopher TA, et al. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation. 1999;99:1685–1691
  15. Fuglesteg BN, Suleman N, Tiron C, Kanhema T, Lacerda L, Andreasen TV, et al. Signal transducer and activator of transcription 3 is involved in the cardioprotective signalling pathway activated by insulin therapy at reperfusion. Basic Res Cardiol. 2008;103:444–453
  16. Gao F, Yue TL, Shi DW, Christopher TA, Lopez BL, Ohlstein EH, et al. p38 MAPK inhibition reduces myocardial reperfusion injury via inhibition of endothelial adhesion molecule expression and blockade of PMN accumulation. Cardiovasc Res. 2002;53:414–422
  17. Liu HR, Tao L, Gao E, Lopez BL, Christopher TA, Willette RN, et al. Anti-apoptotic effects of rosiglitazone in hypercholesterolemic rabbits subjected to myocardial ischemia and reperfusion. Cardiovasc Res. 2004;62:135–144
  18. Li J, Zhang H, Wu F, Nan Y, Ma H, Guo W, et al. Insulin inhibits tumor necrosis factor-alpha induction in myocardial ischemia/reperfusion: role of Akt and endothelial nitric oxide synthase phosphorylation. Crit Care Med. 2008;36:1551–1558
  19. Esumi K, Nishida M, Shaw D, Smith TW, Marsh JD. NADH measurements in adult rat myocytes during simulated ischemia. Am J Physiol. 1991;260:H1743–H1752
  20. Su H, Sun X, Ma H, Zhang HF, Yu QJ, Huang C, et al. Acute hyperglycemia exacerbates myocardial ischemia/reperfusion injury and blunts cardioprotective effect of GIK. Am J Physiol Endocrinol Metab. 2007;293:E629–E635
  21. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 1997;3:917–921
  22. Altieri DC. Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer. 2008;8:61–70
  23. Guha M, Altieri DC. Survivin as a global target of intrinsic tumor suppression networks. Cell Cycle. 2009;8:2708–2710
  24. Bafford R, Sui XX, Wang G, Conte M. Angiotensin II and tumor necrosis factor-alpha upregulate survivin and Kruppel-like factor 5 in smooth muscle cells: potential relevance to vein graft hyperplasia. Surgery. 2006;140:289–296
  25. Blanc-Brude OP, Teissier E, Castier Y, Leseche G, Bijnens AP, Daemen M, et al. IAP survivin regulates atherosclerotic macrophage survival. Arterioscler Thromb Vasc Biol. 2007;27:901–907
  26. Moran EP, Agrawal DK. Increased expression of inhibitor of apoptosis proteins in atherosclerotic plaques of symptomatic patients with carotid stenosis. Exp Mol Pathol. 2007;83:11–16
  27. Abbate A, Scarpa S, Santini D, Palleiro J, Vasaturo F, Miller J, et al. Myocardial expression of survivin, an apoptosis inhibitor, in aging and heart failure. An experimental study in the spontaneously hypertensive rat. Int J Cardiol. 2006;111:371–376
  28. Levkau B, Schafers M, Wohlschlaeger J, von Wnuck Lipinski K, Keul P, Hermann S, et al. Survivin determines cardiac function by controlling total cardiomyocyte number. Circulation. 2008;117:1583–1593
  29. Stenslokken KO, Rutkovskiy A, Kaljusto ML, Hafstad AD, Larsen TS, Vaage J. Inadvertent phosphorylation of survival kinases in isolated perfused hearts: a word of caution. Basic Res Cardiol. 2009;104:412–423
  30. Heusch G, Boengler K, Schulz R. Cardioprotection: nitric oxide, protein kinases, and mitochondria. Circulation. 2008;118:1915–1919
  31. Heusch G. No risk, no ... cardioprotection? A critical perspective. Cardiovasc Res. 2009;84:173–175
  32. Heusch G. Postconditioning: old wine in a new bottle?. J Am Coll Cardiol. 2004;44:1111–1112
  33. Siddall HK, Warrell CE, Yellon DM, Mocanu MM. Ischemia–reperfusion injury and cardioprotection: investigating PTEN, the phosphatase that negatively regulates PI3K, using a congenital model of PTEN haploinsufficiency. Basic Res Cardiol. 2008;103:560–568
  34. Fan WJ, van Vuuren D, Genade S, Lochner A. Kinases and phosphatases in ischaemic preconditioning: a re-evaluation. Basic Res Cardiol. 2010;105:495–511
  35. Burley DS, Ferdinandy P, Baxter GF. Cyclic GMP and protein kinase-G in myocardial ischaemia–reperfusion: opportunities and obstacles for survival signaling. Br J Pharmacol. 2007;152:855–869
  36. Costa AD, Pierre SV, Cohen MV, Downey JM, Garlid KD. cGMP signalling in pre- and post-conditioning: the role of mitochondria. Cardiovasc Res. 2008;77:344–352
  37. Lecour S. Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: does it go beyond the RISK pathway?. J Mol Cell Cardiol. 2009;47:32–40
  38. Boengler K, Hilfiker-Kleiner D, Drexler H, Heusch G, Schulz R. The myocardial JAK/STAT pathway: from protection to failure. Pharmacol Ther. 2008;120:172–185
  39. Skyschally A, van Caster P, Boengler K, Gres P, Musiolik J, Schilawa D, et al. Ischemic postconditioning in pigs: no causal role for RISK activation. Circ Res. 2009;104:15–18
  40. Schwartz LM, Lagranha CJ. Ischemic postconditioning during reperfusion activates Akt and ERK without protecting against lethal myocardial ischemia–reperfusion injury in pigs. Am J Physiol Heart Circ Physiol. 2006;290:H1011–H1018
  41. Bhamra GS, Hausenloy DJ, Davidson SM, Carr RD, Paiva M, Wynne AM, et al. Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening. Basic Res Cardiol. 2008;103:274–284
  42. Hausenloy DJ, Yellon DM. Survival kinases in ischemic preconditioning and postconditioning. Cardiovasc Res. 2006;70:240–253
  43. Li J, Wu F, Zhang H, Fu F, Ji L, Dong L, et al. Insulin inhibits leukocyte–endothelium adherence via an Akt-NO-dependent mechanism in myocardial ischemia/reperfusion. J Mol Cell Cardiol. 2009;47:512–519
  44. Lawlor MA, Alessi DR. PKB/Akt: a key mediator of cell proliferation, survival and insulin responses?. J Cell Sci. 2001;114:2903–2910
  45. Proud CG. Signalling to translation: how signal transduction pathways control the protein synthetic machinery. Biochem J. 2007;403:217–234
  46. Moschella PC, Rao VU, McDermott PJ, Kuppuswamy D. Regulation of mTOR and S6K1 activation by the nPKC isoforms, PKCepsilon and PKCdelta, in adult cardiac muscle cells. J Mol Cell Cardiol. 2007;43:754–766
  47. Huang S, Houghton PJ. Inhibitors of mammalian target of rapamycin as novel antitumor agents: from bench to clinic. Curr Opin Investig Drugs. 2002;3:295–304

PII: S0022-2828(10)00318-4

doi: 10.1016/j.yjmcc.2010.08.017

Journal of Molecular and Cellular Cardiology
Volume 50, Issue 1 , Pages 16-24 , January 2011

Article Tools

* Image Usage & Resolution